The current ALINA trial focused on the EML4-ALK fusion protein second-generation drug alectinib, which enrolled 257 patients with ALK-positive NSCLC in stage IB-IIIA (N2) (7th edition AJCC staging), ...

Laboratory Technical Project Manager Gianmarco Chumbe has been part of the CNET Home team since 2018. He is in charge of developing and carrying out testing procedures for a wide variety of home ...

In the latest market close, Alaska Air Group (ALK) reached $66.66, with a -1.16% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 1.83%.

Over the decades, and influenced by the geopolitics of energy and the need for cleaner sources to power our lives in the era of climate change, civilian efforts have focused on sustaining stable ...

Even once researchers can reliably get more power out of a fusion reaction than they put in, they'll still need to overcome engineering challenges to scale up fusion energy. The experiment ...

George R. Tynan has received research funding from the US Department of Energy and the Office of Fusion Energy Sciences, and has served on numerous advisory panels to DOE and the International ...

The routine biomarkers tested in NSCLC are EGFR, ALK, and ROS1. However, several additional biomarkers have been added ... NGS enables the identification of point mutations, insertions, deletions, ...

View all 2011 Ford Fusion specs. The good: The bad: Editor’s note: This review was written in January 2009 about the 2010 Ford Fusion. Little of substance has changed with this year’s model.

for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). This approval marks an important advancement in ...

FusionBench is a benchmark suite designed to evaluate the performance of various deep model fusion techniques. It aims to provide a comprehensive comparison of different methods on a variety of ...